YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy

BackgroundYTH N6-methyladenosine RNA binding protein 1 (YTHDF1) has been indicated proven to participate in the cross-presentation of tumor antigens in dendritic cells and the cross-priming of CD8+ T cells. However, the role of YTHDF1 in prognosis and immunology in human cancers remains largely unkn...

Full description

Bibliographic Details
Main Authors:	Jian Hu, Dongxu Qiu, Anze Yu, Jiao Hu, Hao Deng, Huihuang Li, Zhenglin Yi, Jinbo Chen, Xiongbing Zu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Series:	Frontiers in Oncology
Subjects:	YTHDF1 prognosis tumor microenvironment immune infiltration immunotherapy human cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.607224/full

Similar Items

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
by: Weiwei Liu, et al.
Published: (2022-08-01)

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma
by: Huihuang Li, et al.
Published: (2022-09-01)

Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma
by: Zhiyong Cai, et al.
Published: (2022-09-01)

Clinical implications of m6A‐related regulators YTHDF1 and YTHDF2 in hepatocellular carcinoma
by: Nanfang Qu, et al.
Published: (2022-12-01)

YTHDF2 is a Potential Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma
by: Ganglin Su, et al.
Published: (2021-08-01)

The mechanism underlying redundant functions of the YTHDF proteins
by: Zhongyu Zou, et al.
Published: (2023-01-01)

YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non–small-cell lung cancer
by: Kazuo Tsuchiya, et al.
Published: (2021-01-01)

m6A binding protein YTHDF2 in cancer
by: Xiaomin Chen, et al.
Published: (2022-04-01)

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
by: Qinfei Zhao, et al.
Published: (2022-07-01)

YTHDF1’s Regulatory Involvement in Breast Cancer Prognosis, Immunity, and the ceRNA Network
by: Wenting Luo, et al.
Published: (2024-02-01)

N6-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target
by: Chao Quan, et al.
Published: (2021-08-01)

Identification of Two m6A Readers YTHDF1 and IGF2BP2 as Immune Biomarkers in Head and Neck Squamous Cell Carcinoma
by: Shaojie Li, et al.
Published: (2022-05-01)

YTHDF3as a prognostic predictive biomarker of thyroid cancer and its correlation with immune infiltration
by: Yihan Zhang, et al.
Published: (2023-09-01)

Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer
by: Anmin Huang, et al.
Published: (2022-09-01)

Erratum: Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer
by: Frontiers Production Office
Published: (2022-12-01)

Prognostic and predictive value of YTHDF1 and YTHDF2 and their correlation with tumor-infiltrating immune cells in non-small cell carcinoma
by: Young Wha Koh, et al.
Published: (2022-11-01)

DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis
by: Ziming Yuan, et al.
Published: (2023-01-01)

Expression of YT Domain Family Protein in Oral Squamous Cell Carcinoma and Its Correlation with the Prognosis
by: Shi R, et al.
Published: (2023-06-01)

The m6A Readers YTHDF1 and YTHDF2 Synergistically Control Cerebellar Parallel Fiber Growth by Regulating Local Translation of the Key Wnt5a Signaling Components in Axons
by: Jun Yu, et al.
Published: (2021-11-01)

Pan-cancer analysis identifies the correlations of Thymosin Beta 10 with predicting prognosis and immunotherapy response
by: Zhanzhan Li, et al.
Published: (2023-05-01)

Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data
by: Chong Shen, et al.
Published: (2023-06-01)

LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response
by: Jihong Huang, et al.
Published: (2022-11-01)

Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human Cancer
by: Kechao Nie, et al.
Published: (2022-05-01)

Research Progress on Relation Between YTHDF1 and Tumors
by: XIAO Shiwei, et al.
Published: (2020-09-01)

Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker
by: Yumei Tang, et al.
Published: (2023-04-01)

An EMT-based risk score thoroughly predicts the clinical prognosis, tumor immune microenvironment and molecular subtypes of bladder cancer
by: Zicheng Xiao, et al.
Published: (2022-09-01)

Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy
by: Yunbo He, et al.
Published: (2022-10-01)

Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer
by: Tong Wu, et al.
Published: (2019-04-01)

Expression and clinical significance of the m6A reader YTHDF2 in peripheral blood mononuclear cells from rheumatoid arthritis patients
by: Fangyi Yao, et al.
Published: (2022-12-01)

The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response
by: Gujie Wu, et al.
Published: (2022-04-01)

Pan-cancer analysis of SERPINE family genes as biomarkers of cancer prognosis and response to therapy
by: Yating Liu, et al.
Published: (2024-01-01)

A Novel YTHDF3-Based Model to Predict Prognosis and Therapeutic Response in Breast Cancer
by: Jie Liu, et al.
Published: (2022-06-01)

A Systematic Pan-Cancer Analysis of CASP3 as a Potential Target for Immunotherapy
by: Zheng Zhou, et al.
Published: (2022-04-01)

PMEPA1 Is a Prognostic Biomarker That Correlates With Cell Malignancy and the Tumor Microenvironment in Bladder Cancer
by: Dongxu Qiu, et al.
Published: (2021-10-01)

The role of CRYAB in tumor prognosis and immune infiltration: A Pan-cancer analysis
by: Lang Cheng, et al.
Published: (2023-01-01)

Prognosis and immunological characteristics of HDAC family in pan-cancer through integrative multi-omic analysis
by: Changsheng Chen, et al.
Published: (2024-03-01)

Melatonin antagonizes ovarian aging via YTHDF2-MAPK-NF-κB pathway
by: Ruigong Zhu, et al.
Published: (2022-03-01)

Progress on Tumor Infiltrating Lymphocytes in Immunotherapy and Prognosis Evaluation of Breast Cancer
by: HONG Chenchen, et al.
Published: (2022-11-01)

Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1
by: Aliaksandr A. Yarmishyn, et al.
Published: (2020-12-01)

Immune Microenvironment Characteristics of Urachal Carcinoma and Its Implications for Prognosis and Immunotherapy
by: Xinke Zhang, et al.
Published: (2022-01-01)